Table 4 Cox's univariate (HR) and multivariate (RR) analysis of the relationship between TLRs expression and relapse-free survival.
From: Study of TLR3, TLR4 and TLR9 in breast carcinomas and their association with metastasis
Factor | Number of patients | Event frequency | HR (95% CI) | RR (95% CI) |
|---|---|---|---|---|
TLR3 | ||||
Score<median>median | 33/33 | 13/28 | 3.4 (1.8-6.7)** | 2.6 (1-3-5.1)** |
CT (-) vs (+) | 14/52 | may-36 | 2.8 (1.1-7.2)* | 2.5 (0-9-6.5)* |
TLR4 | ||||
MIC (-) vs (+) | 58/16 | 29/16 | 3.7 (2-7)** | 3.5 (1.8-6.8)** |
TLR9 | ||||
F (-) vs (+) | 31/42 | 24/21 | 0.4 (0.2-0.7)** | 0.3 (0.3-0.6)** |
Tumoral stage II vs III | 38/20 | 20/17 | 1.9 (1.3-3) ** | 2.8 (1.2-6.5)* |
Progesterone receptors positive vs negative | 42/30 | 31/13 | 0.4 (0.2-0.8)* | 0.3 (0.1-0.7)** |